MedTrace Logo

Characterization of the Use of Antipsychotics in PTSD During the Past Seven Years

NCT00230893 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 99

Last updated 2006-09-21

No results posted yet for this study

Summary

The primary objective is to examine the percentage of patients with PTSD who were prescribed an antipsychotic over the past seven years in the VA Network 7 (AL, GA, SC) and compare the percentage on an annual basis. We will also determine the type and dose of antipsychotics received. We hypothesize that there has been a significant increase in antipsychotic use, especially atypical antipsychotics, prescribed for patients with PTSD over the last 7 years

Conditions

  • PTSD
  • Post-Traumatic Stress Disorder

Sponsors & Collaborators

  • Janssen, LP

    collaborator INDUSTRY

  • Tuscaloosa Research & Education Advancement Corporation

    lead OTHER

Principal Investigators

  • Lori L. Davis, MD · Tuscaloosa Veterans Affairs Medical Center

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-07-31
Completion
2005-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00230893 on ClinicalTrials.gov